Cargando…

Bladder cancer screening: The new selection and prediction model

The objective of this study was to offer new approach for selection of persons with asymptomatic bladder cancer (BC) and highly risky persons for the BC occurrence. Also, it is a part of the BC screening protocol (study is ongoing). Study populations were 100 newly diagnosed (diagnosis maximum 1-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Radosavljevic, Vladan, Milic, Natasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276611/
https://www.ncbi.nlm.nih.gov/pubmed/37333447
http://dx.doi.org/10.1515/med-2023-0723
_version_ 1785060115644153856
author Radosavljevic, Vladan
Milic, Natasa
author_facet Radosavljevic, Vladan
Milic, Natasa
author_sort Radosavljevic, Vladan
collection PubMed
description The objective of this study was to offer new approach for selection of persons with asymptomatic bladder cancer (BC) and highly risky persons for the BC occurrence. Also, it is a part of the BC screening protocol (study is ongoing). Study populations were 100 newly diagnosed (diagnosis maximum 1-year old) males with BC and 100 matched (by sex and age ±5 years) controls (not oncology patients from the same hospital). A hospital based, matched case–control study was done. Statistical analysis comprised of four steps: t-test, univariate logistic regression, multivariate logistic regression, and scoring. The fifth step comprised of two changes, deleting one variable and addition of another variable. Six variables were statistically significant: Caucasian men over 45 years age, tobacco smoking over 40 pack-years, occupational and/or environmental exposure to the proved BC carcinogens over 20 years, macrohematuria, difficulty urinating, BC in relatives up to fourth degree of kinships, and they were used for an easy and fast selection of the individuals with high risk for BC occurrence and BC asymptomatic patients (optimal selection at the population level). The final results showed highly significant probability (p < 0.001), with area under ROC curve of 0.913, negative predictive values of 89.7% (95% CI 10.3–100%), and a specificity of 78%. Positive predictive value was 80.5% (95% CI 19.5–100%) and a sensitivity of 91%. It is possible to recruit asymptomatic BC patients (primary prevention) by using this model, as well as persons with high risk for BC occurrence (primordial prevention). This study is the first part of the BC screening protocol and the second part of the BC screening protocol study is ongoing (urine analysis).
format Online
Article
Text
id pubmed-10276611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-102766112023-06-18 Bladder cancer screening: The new selection and prediction model Radosavljevic, Vladan Milic, Natasa Open Med (Wars) Research Article The objective of this study was to offer new approach for selection of persons with asymptomatic bladder cancer (BC) and highly risky persons for the BC occurrence. Also, it is a part of the BC screening protocol (study is ongoing). Study populations were 100 newly diagnosed (diagnosis maximum 1-year old) males with BC and 100 matched (by sex and age ±5 years) controls (not oncology patients from the same hospital). A hospital based, matched case–control study was done. Statistical analysis comprised of four steps: t-test, univariate logistic regression, multivariate logistic regression, and scoring. The fifth step comprised of two changes, deleting one variable and addition of another variable. Six variables were statistically significant: Caucasian men over 45 years age, tobacco smoking over 40 pack-years, occupational and/or environmental exposure to the proved BC carcinogens over 20 years, macrohematuria, difficulty urinating, BC in relatives up to fourth degree of kinships, and they were used for an easy and fast selection of the individuals with high risk for BC occurrence and BC asymptomatic patients (optimal selection at the population level). The final results showed highly significant probability (p < 0.001), with area under ROC curve of 0.913, negative predictive values of 89.7% (95% CI 10.3–100%), and a specificity of 78%. Positive predictive value was 80.5% (95% CI 19.5–100%) and a sensitivity of 91%. It is possible to recruit asymptomatic BC patients (primary prevention) by using this model, as well as persons with high risk for BC occurrence (primordial prevention). This study is the first part of the BC screening protocol and the second part of the BC screening protocol study is ongoing (urine analysis). De Gruyter 2023-06-16 /pmc/articles/PMC10276611/ /pubmed/37333447 http://dx.doi.org/10.1515/med-2023-0723 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Radosavljevic, Vladan
Milic, Natasa
Bladder cancer screening: The new selection and prediction model
title Bladder cancer screening: The new selection and prediction model
title_full Bladder cancer screening: The new selection and prediction model
title_fullStr Bladder cancer screening: The new selection and prediction model
title_full_unstemmed Bladder cancer screening: The new selection and prediction model
title_short Bladder cancer screening: The new selection and prediction model
title_sort bladder cancer screening: the new selection and prediction model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276611/
https://www.ncbi.nlm.nih.gov/pubmed/37333447
http://dx.doi.org/10.1515/med-2023-0723
work_keys_str_mv AT radosavljevicvladan bladdercancerscreeningthenewselectionandpredictionmodel
AT milicnatasa bladdercancerscreeningthenewselectionandpredictionmodel